Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
OCLI Vision acquires Fishman Center for Total Eye Care
OCLI Vision, which is managed by Blue Sea Capital’s Spectrum Vision Partners, announced that it entered into an agreement to acquire Fishman Center for Total Eye Care. Fishman Center for Total Eye Care is an eye care practice with two locations in Queens, New York. According to its website, the practice is run by three providers. OCLI Vision provides ophthalmic services and treatments, including treatment for cataracts, corneal disease, refractive surgery, glaucoma, oculoplastics, retinal disease and neuro-ophthalmology. Founded in 1997, OCLI Vision offers eye care services at locations throughout Connecticut, New Jersey, New York and Pennsylvania. The Bloom... Read More »
Physician Growth Partners Advises The Woman’s Group in its Acquisition by Femwell
Physician Growth Partners (PGP) announced that it acted as an advisor to The Woman’s Group in its sale to Femwell Group Health. The Woman’s Group is a leading OB/GYN practice with four locations Florida: two in Tampa, one in Lutz and one in Riverview. According to its website, the practice has 29 providers on staff. Femwell Group Health, backed by Los-Angeles, California-based investment firm LightBay Capital, is a leading management services organization providing cost-effective business solutions to physicians. It is based in Miami, Florida. This transaction marks Femwell’s first acquisition of the year. The financial terms were not disclosed. According to... Read More »
Warburg Pincus invests in South Texas Accelerated Research Therapeutics
Warburg Pincus announced that it has secured a majority interest in South Texas Accelerated Research Therapeutics (START). START directs clinical trials of novel anticancer agents. START’s head office is located in San Antonio, Texas, in the heart of the South Texas Medical Center. With centers located in the United States, Spain and China, START conducts the world’s largest Phase I medical oncology program – putting more than 400 patients per year on Phase I trials. Warburg Pincus is a global private equity firm focused on growth investing. Founded in 1966, Warburg Pincus has raised 20 private equity and two real estate funds. It is headquartered in New York with offices across the United... Read More »
Highbridge Capital Management Acquires Gamida Cell for $70 Million
Highbridge Capital Management, based in New York City, announced on March 27 that it entered into an agreement to acquire Gamida Cell, an Israeli biotechnology company. The agreement will see Highbridge Capital Management convert $75 million of existing unsecured convertible senior notes into equity in Gamida as well as supply $30 million of new capital to Gamida. Gamida Cell is a cell therapy pioneer working to turn cells into powerful therapeutics. Its proprietary nicotinamide technology expands the number of cells while maintaining their intrinsic properties to create potentially curative cell therapy products and candidates for patients with cancer. Gamida entered 2024... Read More »
StatLab Medical Products Acquires Poly Scientific R&D
McKinney, Texas-based StatLab Medical Products announced that it has acquired Poly Scientific R&D. Poly Scientific is one of the leading manufacturers of chemicals, stains and reagents for histology, cytology and microbiology, as well as other items for in-vitro diagnostic testing. The company was founded in 1969 and is based in Bay Shore, New York. StatLab Medical Products, an Audax Private Equity and Linden Capital Partners portfolio company, is a McKinney, Texas-based developer and manufacturer of histology, cytology and immunohistochemistry diagnostic products. The company partners with anatomic pathology laboratories to provide easy access to more than 3,500... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
